Effect of N-Terminal Peptide Modifications on In Vitro and In Vivo Properties of (177)Lu-Labeled Peptide Analogs Targeting CCK2R

The therapeutic potential of minigastrin (MG) analogs for the treatment of cholecystokinin-2 receptor (CCK2R)-expressing cancers is limited by poor in vivo stability or unfavorable accumulation in non-target tissues. Increased stability against metabolic degradation was achieved by modifying the C-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hörmann, Anton Amadeus, Klingler, Maximilian, Rangger, Christine, Mair, Christian, Joosten, Lieke, Franssen, Gerben M., Laverman, Peter, von Guggenberg, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058949/
https://www.ncbi.nlm.nih.gov/pubmed/36986657
http://dx.doi.org/10.3390/pharmaceutics15030796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058949/
https://www.ncbi.nlm.nih.gov/pubmed/36986657
http://dx.doi.org/10.3390/pharmaceutics15030796

Ejemplares similares